Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Erythropoietin-SBS 4000 IU vs Hema-Plus 4000 in healthy Thai volunteers
TCTR20210511002Phase 1Not yet recruiting
- Sponsor
- Siam Bioscience Co., Ltd.
- Start
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of erythropoietin in anaemia (2 arms), sponsored by Siam Bioscience Co., Ltd. Primary endpoint: Primary bioequivalence pharmacokinetic parameters. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
erythropoietin
03
Conditions
anaemia
Beyond the preview
Go deeper on TCTR20210511002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210511002.